Posted by Michael Wonder on 29 May 2022
Accelerated approval: unfulfilled promises for FDA’s expedited review program
27 May 2022 - As practicing physicians, approval by the U.S. FDA reassures us that the treatments we prescribe our patients have been rigorously vetted as effective and safe.
For a growing number of drugs, however, FDA approval comes with lingering uncertainty of their benefit.
